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Abstract 
 
Fish may be exposed to an array of pharmaceuticals that are discharged into 
the aquatic environment, paralleling advances in medical knowledge, research 
and technology. Pharmaceuticals by their nature are designed to target specific 
receptors, transporters, or enzymes. Nuclear receptors (NRs) are often a key 
component of the therapeutic mechanism at play, and many of these are 
conserved among vertebrates. Consequently, fish may be affected by 
environmental pharmaceutical exposure, however there has been relatively little 
characterisation of NRs in fish compared with in mammals. In this thesis 
common carp (C. carpio) were exposed to selected pharmaceuticals in vitro and 
in vivo to investigate effects centred on the pregnane X receptor (PXR) and 
peroxisome proliferator-activated receptor alpha (PPARα), two key NRs 
involved in organism responses to pharmaceutical exposure.  The PXR acts as 
a xenosensor, modulating expression of a number of xenobiotic metabolising 
enzymes (XMEs) in mammals. In a primary carp hepatocyte model it was 
shown that expression of a number of XMEs was altered on exposure to 
rifampicin (RIF), as occurs in mammals. This response was repressed by 
addition of ketoconaozle (KET; PXR-antagonist), indicating possible PXR 
involvement. The genes analysed showed up-regulation on exposure to 
ibuprofen (IBU) and clofibric acid (CFA), but not clotrimazole (CTZ) or 
propranolol (PRP). The lack of response to mammalian PXR-agonist CTZ was 
unexpected. In contrast, the same XME genes were found to be up-regulated in 
vivo after 10 days of exposure of carp to CTZ, although this response occurred 
only for a relatively high exposure concentration. CTZ was found to concentrate 
in the plasma (with levels up to 40 times higher than the water).  Development 
and application of a reporter gene assay to measure PXR activation in carp 
(cPXR) and human PXR showed CTZ activation of cPXR, supporting data from 
the in vivo studies. Furthermore, activation was seen at concentrations as low 
as 0.01 µM. Interestingly RIF did not induce a response in the cPXR reporter 
gene assay, contrasting with the hepatocyte culture work. Taken together, the 
data presented here suggests divergence in the PXR pathway between 
mammals and fish in terms of ligand activation and downstream gene targets. 
PPARα was investigated in carp in vivo using CFA as a mammalian PPARα-
agonist. Overall the resulting data suggested a broadly similar role for this NR in 
lipid homeostasis in fish as for mammals, with a number of PPARα-associated 
genes and acyl-coA oxidase (ACOX1) activity up-regulated in response to CFA 
exposure. A number of XMEs were also up-regulated by CFA (in vivo and in 
vitro), potentially extending the role of PPARα in fish (carp) to regulation of 
xenobiotic metabolism. The work presented has provided further 
characterisation of PXR and PPARα in fish. Elucidation of these pathways is 
vital to provide meaningful data in terms of establishing toxicity and mechanism-
of-action data for pharmaceuticals and other compounds in fish, to allow 
validation of read-across approaches and ultimately aid in their environmental 
risk assessment. In vitro approaches are attractive ethically, financially and can 
provide useful mechanistic characterisation of compounds and the primary 
hepatocyte model and reporter gene assays used here show potential for the 
screening of pharmaceutical compounds in fish. However, further understanding 
of the metabolism of drugs and chemicals in fish is required to establish the true 
value of these methods for informing on possible effects in fish, in vivo. 
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